The entire pharmaceutical industry is floated by a protectionist racket. Drugs that are in fact very cheap to make are kept artificially expensive - we have drugs that cost $1,000 a pill here in America that sell for $4 in India, for instance. The means of keeping prices high vary, but include lengthy patents to push production of generics into the future, the barring of foreign competition, and the prohibition of negotiations to lower prices for bulk purchases by both the federal and state governments. Without government intervention, the pharmaceutical industry would be profitable, but it wouldn't be the massive cash factory it is now. In 2015, for instance, the 20 largest drug companies made a collective $124 billion in profits. All the industry needs to protect those sums is the continued cooperation of Congress. So naturally it spends money ... to make sure they always have just enough dependable people in office to block change. Which brings us ... to drug importation. Trump announced early in the race that he was in favor of bringing in cheaper drugs from Canada and made it a big stump theme. The Democrats, meanwhile, put allowing importation of drugs from countries like Canada in their platform last summer. The seeming synergy of the two candidates' positions led to the hope that something might actually be done about the problem, no matter who won. No such luck. Trump's support for drug importation basically went up in smoke from the moment he started filling out his executive appointees.